BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinha N, Jain S, Tilekar A, Upadhayaya RS, Kishore N, Jana GH, Arora SK. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents. Bioorg Med Chem Lett 2005;15:1573-6. [PMID: 15745799 DOI: 10.1016/j.bmcl.2005.01.073] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Alghamdi S, Asif M. Pyrazinamide Analogs Designed for Rational Drug Designing Strategies against Resistant Tuberculosis. Russ J Bioorg Chem 2022;48:491-512. [DOI: 10.1134/s1068162022030037] [Reference Citation Analysis]
2 Al-Khattaf FS, Mani A, Atef Hatamleh A, Akbar I. Antimicrobial and cytotoxic activities of isoniazid connected menthone derivatives and their investigation of clinical pathogens causing infectious disease. J Infect Public Health 2021;14:533-42. [PMID: 33744741 DOI: 10.1016/j.jiph.2020.12.033] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zala M, Vora JJ, Patel HB. Synthesis, Characterization, and Comparative Study of Some Heterocyclic Compounds Containing Isoniazid and Nicotinic Acid Hydrazide Moieties. Russ J Org Chem 2020;56:1795-800. [DOI: 10.1134/s1070428020100218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Gupta A, Pandey S, Yadav JS. A Review on Recent Trends in Green Synthesis of Gold Nanoparticles for Tuberculosis. Adv Pharm Bull 2021;11:10-27. [PMID: 33747849 DOI: 10.34172/apb.2021.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Dueke-eze CU, Fasina TM, Oluwalana AE, Familoni OB, Mphalele JM, Onubuogu C. Synthesis and biological evaluation of copper and cobalt complexes of (5-substituted-salicylidene) isonicotinichydrazide derivatives as antitubercular agents. Scientific African 2020;9:e00522. [DOI: 10.1016/j.sciaf.2020.e00522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bandodkar B, Shandil RK, Bhat J, Balganesh TS. Two Decades of TB Drug Discovery Efforts—What Have We Learned? Applied Sciences 2020;10:5704. [DOI: 10.3390/app10165704] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Suresh R, Sakthinathan SP, Kamalakkannan D, Muthuvel I, Thirunarayanan G. Synthesis and pharmacological evaluation of some benzylidene-4-nitroanilines. Ovidius University Annals of Chemistry 2020;31:55-9. [DOI: 10.2478/auoc-2020-0011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Kumar M, Rani A, Tuli HS, Khare R, Parkash V. Synthesis and Spectral Investigations of Polymeric Hydrazone Schiff Base and its Transition Metal Complexes with Promising Antimicrobial, Anti-Angeogenic and DNA Photo-Cleavage Activities. Asian J Chem 2019;31:2331-6. [DOI: 10.14233/ajchem.2019.22157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Karale UB, Krishna VS, Krishna EV, Choudhari AS, Shukla M, Gaikwad VR, Mahizhaveni B, Chopra S, Misra S, Sarkar D, Sriram D, Dusthackeer VNA, Rode HB. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis. Eur J Med Chem 2019;178:315-28. [PMID: 31195172 DOI: 10.1016/j.ejmech.2019.05.082] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
10 Mohammed Shafeeulla R, Krishnamurthy G, Bhojynaik H, Shivarudrappa H, Shiralgi Y. Spectral thermal cytotoxic and molecular docking studies of N′-2-hydroxybenzoyl; pyridine-4-carbohydrazide its complexes. Beni-Suef University Journal of Basic and Applied Sciences 2017;6:332-44. [DOI: 10.1016/j.bjbas.2017.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
11 Abdelrahman MA, Salama I, Gomaa MS, Elaasser MM, Abdel-aziz MM, Soliman DH. Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents. European Journal of Medicinal Chemistry 2017;138:698-714. [DOI: 10.1016/j.ejmech.2017.07.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 8.5] [Reference Citation Analysis]
12 Kumar V, Patel S, Jain R. New structural classes of antituberculosis agents. Med Res Rev 2018;38:684-740. [DOI: 10.1002/med.21454] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
13 Yurttaş L, Kaplancıklı ZA, Cantürk Z, Karaca Gencer H. Synthesis, Antituberculotic, and Cytotoxic Properties of New Hydrazone Derivatives Bearing Pyrimidine-Alkylsulfanyl Moiety. Phosphorus, Sulfur, and Silicon and the Related Elements 2015;190:1183-91. [DOI: 10.1080/10426507.2014.979984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Pahlavani E, Kargar H, Sepehri Rad N. A Study on Antitubercular and Antimicrobial Activity of Isoniazid Derivative. Zahedan J Res Med Sci 2015;17. [DOI: 10.17795/zjrms1010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
15 Elhakeem MA, Taher AT, Abuel-maaty SM. Synthesis and anti-mycobacterial evaluation of some new isonicotinylhydrazide analogues. Bulletin of Faculty of Pharmacy, Cairo University 2015;53:45-52. [DOI: 10.1016/j.bfopcu.2014.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 dos Reis FD, Gatti IC, Garcia HC, de Oliveira VE, de Oliveira LF. Squaraines: crystal structures and spectroscopic analysis of hydrated and anhydrous forms of squaric acid-isoniazid species. J Phys Chem A 2014;118:11521-8. [PMID: 25436870 DOI: 10.1021/jp509502w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Matei L, Bleotu C, Baciu I, Draghici C, Ionita P, Paun A, Chifiriuc MC, Sbarcea A, Zarafu I. Synthesis and bioevaluation of some new isoniazid derivatives. Bioorg Med Chem 2013;21:5355-61. [PMID: 23823011 DOI: 10.1016/j.bmc.2013.06.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
18 Naveen Kumar HS, Parumasivam T, Jumaat F, Ibrahim P, Asmawi MZ, Sadikun A. Synthesis and evaluation of isonicotinoyl hydrazone derivatives as antimycobacterial and anticancer agents. Med Chem Res 2014;23:269-79. [DOI: 10.1007/s00044-013-0632-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
19 Mavrov MV, Simirskaya NI. New synthesis of ethambutol and related α,β-acetylenic amino alcohols. Pharm Chem J 2013;46:730-5. [DOI: 10.1007/s11094-013-0880-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Ozay H, Yildiz M, Unver H, Kiraz A. Spectroscopic studies and crystal structure of (E)-N′-(2-hydroxy-3-methoxybenzylidene)isonicotinohydrazide. Crystallogr Rep 2013;58:106-10. [DOI: 10.1134/s1063774513010264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Novaković SB, Bogdanović GA, Mohamed SK, Albayati MR, Hameed AS. 2-(1,3-Dioxoisoindolin-2-yl)acetic acid–N′-[(E)-4-methoxybenzylidene]pyridine-4-carbohydrazide (2/1). Acta Cryst E 2012;68:o2897-o2898. [DOI: 10.1107/s1600536812038032] [Reference Citation Analysis]
22 Mohamed SK, Farrukh MA, Akkurt M, Albayati MR, Abdelhamid AA. 2-(1,3-Dioxoisoindolin-2-yl)acetic acid–N′-[(E)-2-methoxybenzylidene]pyridine-4-carbohydrazide (1/1). Acta Cryst E 2012;68:o2442-o2442. [DOI: 10.1107/s1600536812031388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 Kakkar D, Tiwari AK, Chuttani K, Khanna A, Datta A, Singh H, Mishra AK. Design, Synthesis, and Antimycobacterial Property of PEG-bis(INH) Conjugates: PEG-Isoniazid Conjugates as Antimycobacterial Agents. Chemical Biology & Drug Design 2012;80:245-53. [DOI: 10.1111/j.1747-0285.2012.01394.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
24 Ongun MZ, Ertekin K, Gocmenturk M, Ergun Y, Suslu A. Copper ion sensing with fluorescent electrospun nanofibers. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2012;90:177-85. [DOI: 10.1016/j.saa.2012.01.042] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
25 Judge V, Narasimhan B, Ahuja M. Isoniazid: the magic molecule. Med Chem Res 2012;21:3940-57. [DOI: 10.1007/s00044-011-9948-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
26 Jamadar A, Duhme-klair A, Vemuri K, Sritharan M, Dandawate P, Padhye S. Synthesis, characterisation and antitubercular activities of a series of pyruvate-containing aroylhydrazones and their Cu-complexes. Dalton Trans 2012;41:9192. [DOI: 10.1039/c2dt30322a] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
27 Sankar C, Pandiarajan K. Synthesis and anti-tubercular and antimicrobial activities of some 2r,4c-diaryl-3-azabicyclo[3.3.1]nonan-9-one N-isonicotinoylhydrazone derivatives. European Journal of Medicinal Chemistry 2010;45:5480-5. [DOI: 10.1016/j.ejmech.2010.08.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
28 Turan-zitouni G, Kaplancıklı ZA, Özdemir A. Synthesis and antituberculosis activity of some N-pyridyl-N′-thiazolylhydrazine derivatives. European Journal of Medicinal Chemistry 2010;45:2085-8. [DOI: 10.1016/j.ejmech.2010.01.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
29 Eswaran S, Adhikari AV, Pal NK, Chowdhury IH. Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents. Bioorg Med Chem Lett 2010;20:1040-4. [PMID: 20056418 DOI: 10.1016/j.bmcl.2009.12.045] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
30 Abdel-Aal WS, Hassan HY, Aboul-Fadl T, Youssef AF. Pharmacophoric model building for antitubercular activity of the individual Schiff bases of small combinatorial library. Eur J Med Chem 2010;45:1098-106. [PMID: 20045582 DOI: 10.1016/j.ejmech.2009.12.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
31 Hearn M, Cynamon M, Chen M, Coppins R, Davis J, Joo-On Kang H, Noble A, Tu-Sekine B, Terrot MS, Trombino D. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid. Eur J Med Chem. 2009;44:4169-4178. [PMID: 19524330 DOI: 10.1016/j.ejmech.2009.05.009] [Cited by in Crossref: 109] [Cited by in F6Publishing: 117] [Article Influence: 7.8] [Reference Citation Analysis]
32 Hassan HA, Abdel-aziz M, Abuo-rahma GEA, Farag HH. 1-Malonyl-1,4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain. Bioorganic & Medicinal Chemistry 2009;17:1681-92. [DOI: 10.1016/j.bmc.2008.12.051] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
33 Koçyiğit-kaymakçıoğlu B, Elçin Oruç-emre E, Unsalan S, Rollas S. Antituberculosis activity of hydrazones derived from 4-fluorobenzoic acid hydrazide. Med Chem Res 2009;18:277-86. [DOI: 10.1007/s00044-008-9126-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
34 Lourenço MC, Ferreira Mde L, de Souza MV, Peralta MA, Vasconcelos TR, Henriques Md. Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives. Eur J Med Chem 2008;43:1344-7. [PMID: 17923172 DOI: 10.1016/j.ejmech.2007.08.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.1] [Reference Citation Analysis]
35 Rollas S, Küçükgüzel SG. Biological activities of hydrazone derivatives. Molecules 2007;12:1910-39. [PMID: 17960096 DOI: 10.3390/12081910] [Cited by in Crossref: 734] [Cited by in F6Publishing: 753] [Article Influence: 45.9] [Reference Citation Analysis]
36 Imramovský A, Polanc S, Vinšová J, Kočevar M, Jampílek J, Rečková Z, Kaustová J. A new modification of anti-tubercular active molecules. Bioorganic & Medicinal Chemistry 2007;15:2551-9. [DOI: 10.1016/j.bmc.2007.01.051] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 5.1] [Reference Citation Analysis]
37 Janin YL. Antituberculosis drugs: ten years of research. Bioorg Med Chem 2007;15:2479-513. [PMID: 17291770 DOI: 10.1016/j.bmc.2007.01.030] [Cited by in Crossref: 369] [Cited by in F6Publishing: 335] [Article Influence: 23.1] [Reference Citation Analysis]
38 Dixit PP, Patil VJ, Nair PS, Jain S, Sinha N, Arora SK. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents. European Journal of Medicinal Chemistry 2006;41:423-8. [DOI: 10.1016/j.ejmech.2005.12.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]